This website uses cookies

We use cookies to enhance your experience and support COUNTER Metrics for transparent reporting of readership statistics. Cookie data is not sold to third parties or used for marketing purposes.

Skip to main content
null
Clinical Hematology International
  • Menu
  • Articles
    • Case Report
    • Case study
    • Correspondence
    • Editorial
    • General
    • Original Research Articles
    • Perspective Article
    • Research Articles
    • Retrospective study
    • Review Articles
    • Survey
    • Systematic Reviews
    • Technical Notes
    • All
  • For Authors
  • Editorial Board
  • About
  • Issues
  • Blog
  • Blog
  • Conference-Event-Webinar
  • Reviewer Information
  • Open Access Policies
  • search
  • X (formerly Twitter) (opens in a new tab)
  • LinkedIn (opens in a new tab)
  • RSS feed (opens a modal with a link to feed)

RSS Feed

Enter the URL below into your favorite RSS reader.

http://localhost:4849/feed
ISSN 2590-0048
General
Vol. 4, Issue 1-2, 2022May 23, 2022 CDT

The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia

Obada Ababneh, Hassan Abushukair, Aref Qarqash, Sebawe Syaj, Samer Al Hadidi,
Waldenstrom’s MacroglobulinemiaBruton tyrosine kinase inhibitorsIbrutinibZanubrutinib
Copyright Logoccby-4.0 • https://doi.org/10.1007/s44228-022-00007-5

Articles in Vol. 4, Issue 1-2, 2022

Vol. 4, Issue 1-2, 2022
  • Clinical, Diagnostic and Prognostic Characteristics of Primary Cutaneous Gamma Delta T-cell Lymphomas
    Ibrahim N. MuhsenRiad El FakihMehdi HamadaniHillard M. LazarusMohamed A. Kharfan-DabajaMahmoud Aljurf
  • Immunotherapy and Allogeneic Bone Marrow Transplantation in B Acute Lymphoblastic Leukemia: How to Sequence?
    Anna KomitopoulouI. BaltadakisI. PeristeriE. Goussetis
  • The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia
    Obada AbabnehHassan AbushukairAref QarqashSebawe SyajSamer Al Hadidi
  • Safety and Efficacy of Elective Switch from Nilotinib to Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
    Ali IbrahimNour MoukalledRami MahfouzJean El CheikhAli BazarbachiIman Abou Dalle
  • Selected Domains within a Comprehensive Geriatric Assessment in Older Patients with Non-Hodgkin Lymphoma are Highly Associated with Frailty
    María del Pilar Gamarra SamaniegoCarmelo J. BlanquicettRoger V. Araujo CastilloJulio C. ChavezBrady Ernesto Beltrán Garate
  • Retrospective Multicenter Real-Life Study on the First-Line Treatment of Classical Hodgkin Lymphoma in Argentina
    Carolina MahuadOtero VictoriaKorin LauraMartinez EnriquetaWarley FernandoGarcía Rivello HernánCristaldo NancyKohan DanaZerga MartaGarate GonzaloVicente Repáraz María de los ÁngelesAizpurua FlorenciaRojas Bilbao EricaCerana SusanaFunes Maria EugeniaPlaza IlianaFoncuberta CeciliaVijnovich Baron AnahíCranco SantiagoVitriu AdrianaGomez MarielaLavalle JustinaCasali ClaudiaClavijo ManuelaMelillo LucianaCabral Lorenzo Maria CeciliaMiroli AugustoFischman LauraPavlove MaximilianoMiodosky MarcelaCugliari Silvana
  • Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine
    Marco ManzoniAlessandro BosiSonia FabrisMarta LionettiSimone SalerioAnna Chiara MiglioriniFrancesca CavallaroKordelia BarbullushiNicolò RampiVittorio MontefuscoMaria Grazia AlessioAntonino NeriLuca BaldiniMariarita SciumèElena TagliaferriNicola FracchiollaNiccolò Bolli
  • Trends in Inpatient Chemotherapy Hospitalizations, Cost and Mortality for Patients with Acute Leukemias and Myeloma
    Kellen GilSaqib AbbasiKathan MehtaBrian McCluneDouglas SborovNausheen AhmedAl-Ola AbdallahSiddhartha GangulyJoseph McGuirkLeyla ShuneGhulam Rehman Mohyuddin
  • Invasive Fungal Rhinosinusitis Due to Co-infection with Mucormycosis and Exserohilum rostratum in a Patient with Acute Lymphoblastic Leukemia
    Vera RadiciEolia BrissotSuzanne ChartierJuliette GuitardBettina FabianiMara MemoliAnne BanetLaurence HeubergerSimona LapusanSarah AtallahOllivier LegrandAlexis Genthon
Clinical Hematology International
Ababneh, Obada, Hassan Abushukair, Aref Qarqash, Sebawe Syaj, and Samer Al Hadidi. 2022. “The Use of Bruton Tyrosine Kinase Inhibitors in Waldenström’s Macroglobulinemia.” Clinical Hematology International 4 (1–2): 21–29. https://doi.org/10.1007/s44228-022-00007-5.
Save article as...▾

View more stats

Powered by Scholastica, the modern academic journal management system